Insider Stock Trading History of Glaxosmithkline Plc


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Glaxosmithkline Plc since year 2005. The trader's CIK number is 1131399. At the time of this reporting, Glaxosmithkline Plc is the of Htg Molecular Diagnostics, Inc . (stock ticker symbol HTGM). See this page for all insider trading activities at Htg Molecular Diagnostics, Inc .

Note that in the past GLAXOSMITHKLINE PLC also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Glaxosmithkline Plc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-03-27 HTGM Htg Molecular Diagnostics, Inc Sale 300,000 10.15 3,045,300
2016-10-24 CRSP Crispr Therapeutics Ag Buy 66,500 14.00 931,000
2016-03-14 TBPH Theravance Biopharma, Inc. Buy 1,301,015 23,027,965.50 29,959,728,534,982
2015-10-07 TBPH Theravance Biopharma, Inc. Buy 44,574 607,543.62 27,080,649,317
2015-08-07 THRX Theravance Inc Buy 245,828 3,485,841.04 856,917,331,181
2015-05-11 HTGM Htg Molecular Diagnostics, Inc Buy 365,106 14.00 5,111,484
2015-05-11 THRX Theravance Inc Buy 85,579 1,369,264.00 117,180,243,856
2015-03-02 THRX Theravance Inc Buy 92,674 1,673,692.44 155,107,773,184
2015-02-23 AGTC Applied Genetic Technologies Corp Sale 503,150 22.00 11,069,803
2014-12-17 AGTC Applied Genetic Technologies Corp Sale 8,000 21.00 168,000
2014-12-10 AGTC Applied Genetic Technologies Corp Sale 10,000 21.18 211,759
2014-12-12 AGTC Applied Genetic Technologies Corp Sale 7,500 21.24 159,292
2014-12-11 AGTC Applied Genetic Technologies Corp Sale 12,500 21.28 266,037
2014-12-18 AGTC Applied Genetic Technologies Corp Sale 12,000 21.01 252,132
2014-11-04 THRX Theravance Inc Buy 832,456 12,786,524.16 10,644,218,756,136
2014-10-27 FOLD Amicus Therapeutics Inc Sale 11,315,825 5.29 59,872,030
2014-08-11 THRX Theravance Inc Buy 172,651 3,912,271.66 675,457,614,370
2014-05-09 THRX Theravance Inc Buy 317,770 8,544,835.30 2,715,292,313,281
2014-04-01 AGTC Applied Genetic Technologies Corp Buy 103,762 12.00 1,245,144
2014-02-19 CNCE Concert Pharmaceuticals, Inc. Buy 35,000 14.00 490,000
2014-02-11 THRX Theravance Inc Buy 342,229 12,850,698.95 4,397,881,850,959
2014-02-10 GNCA Genocea Biosciences, Inc. Buy 143,773 12.00 1,725,276
2013-11-20 FOLD Amicus Therapeutics Inc Buy 1,500,000 2.00 3,000,000
2013-10-29 THRX Theravance Inc Buy 130,473 4,913,613.18 641,093,852,434
2013-07-30 THRX Theravance Inc Buy 3,064,407 111,850,855.50 342,756,544,550,188
2013-04-30 THRX Theravance Inc Buy 193,563 6,699,215.43 1,296,720,236,277
2013-02-15 THRX Theravance Inc Buy 116,527 2,567,089.81 299,135,274,289
2012-11-02 THRX Theravance Inc Buy 280,348 6,265,777.80 1,756,598,274,674
2012-08-03 THRX Theravance Inc Buy 316,334 28.21 8,923,782
2012-08-01 HGSI Human Genome Sciences Inc Buy 5,686,715 14.25 81,035,688
2012-08-02 HGSI Human Genome Sciences Inc Buy 62,646,186 14.25 892,708,150
2012-08-01 HGSI Human Genome Sciences Inc Buy 1,788,186 14.25 25,481,650
2012-07-30 HGSI Human Genome Sciences Inc Buy 4,934,743 14.25 70,320,087
2012-07-17 FOLD Amicus Therapeutics Inc Buy 2,949,581 6.30 18,582,360
2012-05-16 THRX Theravance Inc Buy 10,000,000 21.29 212,890,000
2012-02-14 THRX Theravance Inc Buy 88,468 18.12 1,603,040
2011-11-01 THRX Theravance Inc Buy 58,411 22.23 1,298,476
2011-05-03 THRX Theravance Inc Buy 261,299 25.60 6,689,254
2011-02-18 THRX Theravance Inc Buy 152,278 23.70 3,608,988
2011-01-31 DGX Quest Diagnostics Inc Sale 30,755,151 54.96 1,690,241,588
2010-11-29 THRX Theravance Inc Buy 5,750,000 22.50 129,375,000
2010-11-24 ANAC Anacor Pharmaceuticals Inc Buy 1,000,000 5.00 5,000,000
2009-03-17 DGX Quest Diagnostics Inc Sale 500,000 45.50 22,749,000
2009-03-18 DGX Quest Diagnostics Inc Sale 500,000 46.04 23,019,000
2009-03-19 DGX Quest Diagnostics Inc Sale 4,749,157 44.64 212,016,615

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Glaxosmithkline Plc ( of Htg Molecular Diagnostics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.